ID: ALA5209542

Max Phase: Preclinical

Molecular Formula: C18H16N2O4S

Molecular Weight: 356.40

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1cccc2occc12)c1ccccc1NS(=O)(=O)C1CC1

Standard InChI:  InChI=1S/C18H16N2O4S/c21-18(19-15-6-3-7-17-13(15)10-11-24-17)14-4-1-2-5-16(14)20-25(22,23)12-8-9-12/h1-7,10-12,20H,8-9H2,(H,19,21)

Standard InChI Key:  NSRDWXLFMANRRP-UHFFFAOYSA-N

Associated Targets(Human)

Mas-related G-protein coupled receptor member X1 365 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 356.40Molecular Weight (Monoisotopic): 356.0831AlogP: 3.59#Rotatable Bonds: 5
Polar Surface Area: 88.41Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.60CX Basic pKa: CX LogP: 2.37CX LogD: 2.19
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.73Np Likeness Score: -1.19

References

1. Sharma S, Peng Q, Vadukoot AK, Aretz CD, Jensen AA, Wallick AI, Dong X, Hopkins CR..  (2022)  Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1.,  13  (5.0): [PMID:35586421] [10.1021/acsmedchemlett.2c00100]

Source